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Nonna! hwnan diploid fibroblasts (HDF) have a finite 
proliferative life-span at the end of which they are arrested 
with a Gl phase DNA content regardless of the culture 
conditions. Serum stimulated senescent HDF fail to 
phosphorylate their retinoblastoma protein (pRb) and 
consequently do not express a large cohort of late Gl 
phase genes whose products are necessary for entry into 
S phase. Because pRb is believed to be phosphorylated 
sequentially in Gl phase by cyclin D-CDK4/6 and cyclin 
E-CDK2 complexes. we and others have investigated the 
status of these complexes in senescent HDF. There is 
little or no cyclin E-associated kinase activity in senescent 
IMR90 even though potentially active cyclin E-CDK2 
complexes are present, suggesting the presence of an 
inhibitor. Likewise. cyclin D is complexed with its cata-
C ultured human diploid fibroblasts have a finite proliferat­ive life-span that ends in a viable cell cycle arrest that cannot be bypassed by manipulating the culture conditions. This phenomenon of cellular aging or cellular senescence is an intrinsic property of most 
normal human diploid cells, but it has been studied most extensively 
in human diploid fibroblasts (HDF). HDF derived from fetal or 
neonatal tissue usually senesce after 50-80 population doublings, and 
the end of life-span is typically defined as the point when the population 
can no longer achieve one doubling in 2-3 wk, with weekly refeeding. 
CELL CYCLE ARREST AT THE END OF THE LIFE-SPAN 
Populations of senescent HDF have a negligible ability to synthesize 
DNA such that fewer than 5% of the cells incorporate eH]thymidine 
during a 24 h period in a sparse, serum-stimulated culture, i.e., their 
labeling index is low (Cristofalo and Sharf, 1973). Senescent HDF 
have single, unduplicated chromatids, implying that they are arrested 
in GO/G1 even though some endoreduplication occurs, especially in 
cells that are held at senescence for long periods of time (Yanishevsky 
and Carrano, 1975; Bayreuther et aI, 1992). YoungHDF are also arrested 
with GO/G1 phase DNA contents when they become quiescent, owing 
to cell crowding and/or serum deprivation, but in this case the arrest 
is reversible by either sub cultivation or serum stimulation. Comparison 
of the mechanism for the irreversible cell cycle arrest in senescent 
HDF and the reversible arrest in quiescent HDF has been an important 
experimental paradigm for understanding the molecular basis for cellular 
senescence. 
Reprint requests to: Dr. Gretchen H. Stein, Department of Molecular, 
Cellular & Developmental Biology, Campus Box 347, University of Colorado, 
Boulder, CO 80309-{)347. 
Abbreviations: CDK, eyelin-dependent kinase; HDF, human diploid 
fibroblasts. 
lytic partners CDK4 and CDK6 in senescent HDF, but 
it is not known whether these complexes are active. 
p21 Sdil,Cipl,Wafl, a ubiquitous inhibitor of the activity of 
cyclin-CDK complexes, increases progressively through­
out the life-span of HDF. but then declines again after 
the cells become senescent. In contrast, p16Ink4a, which 
binds monomeric CDK4 and CDK6 thereby preventing 
their binding to cyclin D. is increased dramatically at the 
time of senescence and remains high for at least 2 
mo. Thus, it is possible that increased p21 initiates the 
senescent cell cycle arrest in nonnal cells, but p16 is 
important for the long-tenn maintenance of that arrest. 
Key words: cyetin-dependent kinases/G1 cyclins/p161nk4• / 
p21Sdit,Cipl, Wtifl. Journal of Investigative Dermatology Sympo­
sium Proceedings 3:14-18, 1998 
INDEPENDENCE OF THE AGING PROCESS FROM 
SENESCENT CELL CYCLE ARREST 
The aging process that causes a cell to have a finite proliferative 
capacity, and the ability to enter the senescent arrest state at the end 
of the life-span, are separable properties. This phenomenon is illustrated 
by the behavior of both pre-crisis SV 40-transforrned cells and somatic 
cell hybrids formed between normal HDF and "immortal" transformed 
cells. Pre-crisis SV40-transforrned HDF have a finite proliferative life­
span even though it is 20-30 population doublings longer than their 
nontransformed counterparts, yet these cells are unable to arrest in the 
senescent state at the end of the life-span. Instead, they continue to 
synthesize DNA at the end of the life-span, their cell number declines 
owing to an increase in cell death, and eventually the culture is lost 
in its "crisis" (Stein, 1985). Immortalized variants arise from these 
cultures at a very low frequency (""3 X 10-7) (Shay et aI, 1993a). 
Somatic cell genetic studies have shown further that finite proliferative 
life-span is a dominant phenotype in cell hybrids formed between 
normal cells and immortalized cells (Pereira-Smith and Smith, 1988); 
however, the ability to enter a viable, senescent arrest at the end of 
the life-span is often recessive in such hybrids, implying that how a 
cell behaves at the end of the life-span is under separate genetic control 
from the aging process that ultimately limits life-span (Stein et aI, 
1985). Thus, cells are transfoffiled to immortality by recessive mutations, 
but they can lose cile ability to arrest in the cell cycle by both dominant 
and recessive mechanisms, which are independent of the aging process 
per se. 
DIFFERENTIATION OF SENESCENT HDF 
When normal HDF become senescent, they also differentiate further. 
For example, senescent HDF are larger and morphologically altered 
compared with young cells, they express a senescence-associated �­
galactosidase activity that is largely absent from young cells (Dimri 
et aI, 1995), and they produce an altered complement of extracellular 
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Figure 1. Summary of serum-inducible events in senescent HDF versus 
young quiescent HDF. Serum-stimulated quiescent HDF carry out all of the 
events shown in the diagram. whereas serum-stimulated senescent HDF are 
deficient in the events crossed out with dashed lines (Seshadri and Campisi, 
1990; Stein et ai, 1990, 1991; Duli(; et ai, 1993; Hara el ai, 1994; Pang and 
Chen, 1994; Good e/ ai, 1996). Senescent HDF also have increased amounts 
of cyclin D1, cyclin E, p21, and p16 both before and after serum stimulation, 
as indicated by the bold arrows (Dulic et ai, 1993; Noda el ai, 1994; Alcorta 
et aI, 1996; Han et aI, 1996). 
matrix components and modifYing enzymes (West et ai, 1989; Millis 
et ai, 1992). Because production and modification of the extracellular 
matrix is a primary differentiated function of HDF, these alterations 
imply that senescence alters the cell-type specific functions offibroblasts. 
Skin biopsies from older individuals have a greater proportion of 
senescent cells in situ and a lesser proliferative capacity in culture, 
suggesting that these changes also take place in vivo (Bayreuther et aI, 
1992). It is possible that this "maturation" or "terminal differentiation" 
of a certain percentage of young, less differentiated fibroblasts is 
important for extracellular matrix modification and turnover at all ages, 
but becomes detrimental as it increases in frequency with aging. 
Thus, cellular aging of normal HDF involves three distinct processes : 
(i) the aging process itself (the mitotic clock), such as telomere 
shortening (Harley et aI, 1990) that informs a cell of its replicative age 
and presumably drives the other changes ; (ii) the mechanism conferring 
irreversible cell cycle arrest; and (iii) the mechanism for the differenti­
ation that takes place in senescent cells. In this paper, we will 
focus primarily on the mechanism for irreversible cell cycle arrest in 
senescent HD F. 
FAILURE TO PASS THE R POINT IN SENESCENT HDF 
Although senescent HDF cannot be induced to synthesize DNA by 
serum stimulation, they are able to respond to serum stimulation by 
expressing a number of the same genes as do serum-stimulated quiescent 
HDF, particularly in early and mid-G1 phase (Fig 1). On the other 
hand, c-fos, which encodes a component of AP-1 transcription factors , 
and Id1H and Id2H, which encode helix-loop-helix proteins that may 
act as inhibitors of differentiation, are important immediate early genes 
that fail to be expressed in senescent HDF (Seshadri and Campisi, 
1990; Hara et aI, 1994). Late G1 events are even more dramatically 
affected, i.e. senescent HDF are unable to express a large cohort of 
late G 1 genes whose products are necessary for entry into S phase 
(Fig 1). These include cell cycle regulatory molecules such as cyclin 
A, cdc2, and E2F1 (Dimri et ai, 1994; Stein et ai, 1991), as well as 
genes whose products are necessary for DNA synthesis such as 
dihydrofolate reductase, PCNA, and the histones (pang and Chen, 
1994). These data suggest that senescent cells are unable to pass the 
restriction point (R point), which has been defmed as the event or 
process that commits a cell to DNA synthesis and mitosis without the 
need for further mitogenic stimulation (Pardee, 1989) . 
In mammalian cells, phosphorylation of the retinoblastoma protein 
(PRb) has characteristics of an R point event because unphosphorylated 
pRb binds transcription factors, such as E2F, whose activities are 
important for the expression of the late G1 genes described above 
(Cobrinik et ai, 1992; Nevins, 1992). In stimulated quiescent cells, 
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pRb phosphorylation begins to increase in rnid-G 1 and increases as 
the cells progress through late G1, as well as Sand G2 phase, ther eby 
relieving its inhibitory activity. We have shown that in stimulated 
senescent cells, pRb phosphorylation fuils to take place (Fig 2c), 
consistent with the lack oflate G 1 gene expression in these cells (Stein 
et ai, 1990). Thus, fuilure to phosphorylate pRb is a pivotal event in 
the inability of these cells to enter S phase, making it important to 
understand why pRb is not phosphorylated in senescent HDF. It is 
crucial, however, to note that overcoming the inhibitory activity of 
unphosphorylated pRb and possibly other pRb-related proteins by 
transfection with pRb-binding proteins such as SV40 T-antigen or 
human papillomavirus E7 , does not confer immortality on HDF. 
Rather, it impairs the ability of the cells to enter the senescent artest 
state with the consequence that they have an extended life-span that 
ends in cell death. 
G1 CYCLINS AND CYCLIN-DEPENDENT KINASES IN 
SENESCENT HDF 
Phosphorylation of pRb during the G 1 to S phase transition is carried 
out by cyclin-dependent kinases (CDK) complexed to their G1 cyclin 
regulatory partners , cyclin D and cyclin E (Sherr, 1994). These G1 
cyclins are typically present at low amounts in quiescent cells, with 
cyclin D1 increasing first at about 6 h after serum stimulation followed 
by cyclin E at 9 h after stimulation in IMR90, a typical HDF. In 
contrast, we have found that both cyclin 01 and cyclin E are present 
in unusually high amounts both before and after serum stimulation in 
senescent LMR90 (Fig 2a) (Dulic et aI, 1993). Nevertheless , there is 
lirtle or no cyclin E-associated kinase activity in serum-stimulated 
senescent cells in comparison with serum-stimulated quiescent cells 
(Fig 2b). Inactivity of the cyclin E-CDK2 complexes cannot be 
explained solely by regulatory phosphorylation of CDK2, which is at 
least partially in the activated Thr160-phosphorylated form (Dulic et ai, 
1993). Moreover, the senescent cyclin E-CDK2 complexes could not 
be activated by Cdc25 protein phosphatase, which removes inactivating 
phosphorylations at Thr14 and Tyr15. These data suggested that the 
cyclin E-CDK2 complexes in senescent cells might be bound to an 
inhibitor. Since then, multiple inhibitors of cyclin-dependent kinases 
have been discovered, making it important to determine what role 
they play in the senescent cell cycle artest (Sherr and Roberts, 1995). 
Although cyclin D is associated with its catalytic partners CDK4 
and CDK6 in senescent cells (Alcorta et ai, 1996; Dulic and Stein, in 
preparation), there is still uncertainty about whether these complexes 
are active in senescent cells. First, owing to technical difficulties, data 
showing cyclin D-associated kinase activity in senescent cells are still 
not available. Second, the lack of hyperphosphorylation of pRb in 
senescent HDF (Stein et aI, 1990) does not rule out the possibility that 
pRb may be hypophosphorylated (i.e., no mobility shift) in senescent 
cells. Interestingly, it has been shown recently that the hypophosphoryl­
ation of pRb that takes place in early G 1 is carried out by e ndogenous 
cyclin D-CDK4/6 complexes (Ezhevsky et ai, 1997). Third, one cannot 
infer a lack of cyclin D-associated kinase activity from the lack of E2F 
activity in serum-stimulated senescent cells (Good et ai, 1996), because 
hypophosphorylation ofpRb by cyclin D-CDK4/6 does not cause the 
release of E2F transcription factors (Ezhevsky et ai, 1997). Thus, it is 
still possible that senescent HDF have cyclin D-associated kinase 
activity and hypophosphorylated pRb. If so, then the lack of cyclin 
E-associated kinase activity alone might mediate the senescent cell 
cycle arrest at the R point. 
INHIDITORS OF CDK IN SENESCENT HDF 
Senescent cells contain unusually high amounts of two CDK inhibitors, 
i.e., p21 Sdil.Cipl.Wafl (Noda et ai, 1994) and p16Ink4' (Alcorta et ai, 
1996; Hara et ai, 1996) . These two inhibitors have different modes of 
action and reach their peak amounts at different times in senescent 
cells (Fig 3). p21 is an ubiquitous inhibitor of cyclin/CDK complexes 
that binds to the complexes and is thought to inhibit them stoichi­
ometrically (Xiong et aI, 1993; Zhang et ai, 1994). Interestingly, two 
studies found that p21 is also present in active cyclin-COK complexes 
(Zhang et ai, 1994; Harper et ai, 1995). In addition, p21 is required 
16 STEIN AND DULle JID SYMPOSIUM PROCEEDINGS 
a 
Quiescent (Young) Senescent b Quiescent (Young) Senescent 
Figure 2. Gl eyelin proteins in quiescent 
and senescent cells at various tUnes after 
serum stUnulation. (a) Western blots of cell 
lysates from IMR90 cells in different growth 
states were fractionated on 11% sodium dodecyl 
sulfute-polyacrylamide gel electrophoresis and 
immunoblotted sequentially with antibodies to 
eyclins E, Dl, and A. (b) Anti-eyclin A and 
anti-cyelin E immune complexes were 
immunoprecipitated from aliquots of the same 
cell extracts used for (a). Kinase activity of the 
complexes was measured using histone H 1 as 
the substrate. (e) Western blots, prepared using 
8% sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis were immunoblotted 
sequentially for cyclin E and pRb. (Figure taken 
from Stein et aI, 1994) 
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Figure 3. Effect of aging on p21 and p16 in IMR90 ceUs . Cell lysates 
prepared from quiescent IMR90 HDF at different ages were immunoblotted 
with antibodies to p21 (Transduction Laboratories, Lexington, KY) and p16 
(Santa Cruz, CAl. and the results were quantitated by ECL chemiluminescence 
(Amersharn, Arlington Heights, ILl. When the cells became senescent at the 
end of the life-span, additionallysates were analyzed at 1 and 2 rno after cell 
cycle arrest was achieved. The data are presented in arbitraty units for each 
inhibitor to show the age-related changes. 
for efficient cyclin D-CDK4/6 association and activation in vitro 
(LaBaer et aI, 1997). On the other hand, several reports indicate that 
only p21-free cyclin AIE-CDK2 complexes are active in human cell 
lysates (Bresnahan et ai, 1996; Planas-Silva and Weinberg, 1997; Dulic 
et ai, 1998). Taken together, these studies suggest that p21 can play 
both a positive and a negative role in regulating cyclin-CDK activity, 
depending on which type of complex is involved and how many 
molecules of p21 are bound. In contrast, p16 binds to monomeric 
CDK4 and CDK6, thereby preventing their association with cyclin D 
(Serrano et aI, 1993). Other CDK inhibito� related to either p21 
cyclin E 
cyclin A 
12 18 24 0 6 12 18 24 
Time after stimulation (hI'S) 
Figure 4. Expression of the senescence-associated b-galactosidase 
activity in IMR90 HDF following treatment with mitomycin C. Young 
quiescent IMR90 were treated with 1.5 X 10--<5 M mitomycin C (Sigma, St 
Louis, MO) for 48 h, then rinsed and sub cultivated into fresh medium at low 
density to allow the senescent-like differentiation to take place. Cells were 
fixed and stained for SA-I3-galactosidase activity (Dimri et aI, 1995). (a) Untreated 
young IMR90, (b) young IMR90 1 rno after mitomycin C treatment, and (e) 
senescent IMR90 2 mo afrer the end of the life-span. 
(p27Kip1 and pS7Kip2) o� p16 (plSInk4b, p181nk4c, and p191nk4d) were 
either not expressed in HDF or not increased in senescent HDF in 
comparison with young HDF (Robetorye et aI, 1996). 
The first studies on p21 showed that its mRNA increased gradually 
as cells aged and reached a maximum 10- to 20-fold increase in newly 
senescent cells (Noda et ai, 1994). The amount of p21 protein also 
increases gradually throughout the life-span of HDF, with an overall 
rise of about 5-fold in senescent IMR90 cells (Fig 3). Recent studies, 
however, show that the amount of p21 does not stay at high levels in 
senescent cells that are maintained in culture over the long-term. Two 
months after senescence is achieved, the amount of p21 in senescent 
IMR90 is comparable with that in IMR90 populations that have 
completed less than half their proliferative life-span (Fig 3). In another 
HDF. MRCS, it appears that the amount of p21 reaches its peak 1-3 
population doublings before the culture is fully senescent (Alcorta el ai, 
1996). Because disruption of the p21 gene in HDF by targeted 
homologous recombination causes these cells to have an extended life­
span that resembles crisis at its end (Brown et aI, 1997), p21 appears 
to playa critical role in the normal senescent cell cycle arrest. 
Unlike p21, the basal amount of p16 remains steady throughout 
most of the life-span of HDF. but rises dramatically after proliferation 
has ceased (Alcorta et aI, 1996; Hara et aI, 1996) and remains high for 
at least 2 mo after the end of the life-span (Fig 3). Thus, it is possible 
that elevated p 16 is important for maintenance of the senescent cell 
cycle arrest, whereas elevated p21 may be necessary for entry into the 
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arrest state. In senescent MRC-5 cells, the majority of CDK4 and 
CDK6 are associated with p16, with the remainder in complexes that 
contained p21 (Alcorta et ai, 1996). Nevertheless, there may be cyclin 
D-CDK4/6 activity in senescent HDF because other studies have 
indicated that most of cellular eyclin D-associated kinase activity is 
found in complexes that contain p21 (Zhang et aI, 1994; LaBaer et aI, 
1997). This may reflect the fact that in vitro, p21 promotes the 
association of eyclin Dl with its catalytic partners, leading to increased 
kinase activity. Thus, at present, we do not know whether the presence 
ofp21 in cyclin D-CDK4/6 complexes from senescent cells promotes 
or inhibits eyclin D-associated kinase activity. 
RELATIONSHIP BETWEEN DNA DAMAGE AND AGING 
Although the mechanism responsible for the increase in p21 with aging 
is not known, several lines of evidence suggest that it could be related 
to a DNA damage response pathway; however, the picture is far from 
clear and some of the results are controversial. First, p21 rnRNA and 
protein are increased in response to a variety of DNA damaging 
agents, e.g., ionizing radiation, ultraviolet radiation. hydrogen peroxide, 
mitomycin C, and many others (Dulic et ai, 1994; El-Deiry et ai, 1994; 
Johnson et aI, 1994). Second, senescent and near-senescent HDF sustain 
and retain a higher amount of endogenous oxidative damage to their 
DNA than do young HDF (Chen et aI, 1995). Taken together, these 
results suggest that endogenous DNA damage might cause the age­
related increase in p21. In contrast, there is no evidence for an increase 
in p16 as an inunediate consequence of DNA damage (Shapiro et ai, 
1998). Consistent with this, p16 does not increase during the aging 
process in HDF, but rather rises dramatically after the cells become 
senescent. 
In many cases, DNA damage leads to increased p53, which is a 
positive transactivator of p21, suggesting that this might be the 
mechanism by which p21 mRNA and protein are increased in senescent 
HDF. Indeed, p53-deficient HDF have an extended life-span (Shay 
etaI, 1993b; Bond et ai, 1994), and some studies have reported increased 
p53 protein in near-senescent HDF (Kulju and Lehman, 1995) or 
increased p53 transactivating activity in senescent HDF (Atadja et ai, 
1995). Other reports, however, indicate that p53 protein is not 
increased in senescent HDF (AfShari et ai, 1993; Atadja et ai, 1995). 
Furthennore, run-on analysis of young and senescent HDF indicates 
that the rate of transcription of p21 is not increased in the senescent 
cells, nor is there increased activity of various p21 reporter constructs 
in senescent cell lysates, suggesting that p21 mRNA may increase 
during aging owing to stabilization rather than increased synthesis 
(Campisi, 1997). 
At present, it is not clear how to reconcile all of the above results, 
but the answer may lie in recognizing that senescence is not a static 
condition, as illustrated by the decline in p21 and the rise in p16 after 
senescence is achieved. Therefure, it is pOSSIble that both increased 
transactivation by p53 and increased p21 mRNA stabilization may be 
important as the cells approach senescence, but once the cells cease 
replicating, p53 is no longer elevated in either amount or activity. 
Although speculative, this hypothesis would also suggest that the 
amount of p21 slowly declines after the cells become sensecent because 
stabilization of p21 mRNA alone is not sufficient to maintain p21 at 
its peak amount. 
Finally, when young HDF are treated with the DNA damaging 
agents mentioned above, they are induced to arrest in the cell eycle 
in a manner that strongly resembles a senescent arrest phenotype 
(Rodemann et ai, 1989; DiLeonardo et aI, 1994; Chen et ai, 1995). 
The treated cells are irreversibly arrested, enlaIged, and mOIphologically 
altered, and they express the senescence-associated �-galactosidase 
activity (Fig 4). Senescent HDF also overexpress several of the same 
extracellular matrix remodeling genes that are induced by ultraviolet 
irradiation of human skin (Fisher et ai, 1996; West et ai, 1989; Millis 
et aI, 1992). Thus, these data are consistent with the hypothesis that a 
DNA damage response mechanism could underlie a number of the 
age-related changes that are characteristic of old HDF in culture. This 
possibility is of particular interest for human skin, which is subject to 
an additional source of DNA damage owing to the ultraviolet radiation 
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present in sunlight. Thus, sun exposure could accelerate intrinsic aging 
processes as well as induce changes that are specific to sun-exposed skin. 
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